Clinical Trial Update: Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating methylphenidate for epilepsy-related cognitive deficits and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Epilepsy | Phase 4 | Status: RECRUITING